Pharming Group

Pharming Group: Building a sustainable rare disease business, preparing for approval/launch of leniolisib for APDS. Revenues >$200M (TTM) from Ruconest (marketed) for the treatment of acute hereditary angioedema (HAE) attacks including breakthrough attacks. Leniolisib, a targeted PI3Kδ inhibitor initially being developed for PI3K delta syndrome (APDS), is on track to be the first approved disease-modifying treatment for APDS, a rare genetic immunodeficiency. Regulatory approvals expected from the US FDA in Q1 2023 and EU EMA in H1 2023 under priority review/ accelerated assessment, with commercial launch expected in the US H1 and EU H2 2023. Ruconest cash flow funds leniolisib and broader pipeline development. Dual listed on Nasdaq.
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
Europe
Clinical Stage
Marketed, Registration Stage
Disease Space
Anti-inflammatory, Complement Mediated, Rare Disease
Finance
Profitable, Revenues
Industry
Biotechnology
Listing
Public, USA
Market Cap
500MM - 1B
Therapeutic Modalities
pi3k, Recombinant DNA, Small Molecule, Targeted Therapy
Website:
Profiles:
Address:
Vondellaan 47
Leiden, Zuid-Holland 2332AA
Netherlands

Company Participants at Solebury 1x1 Management Access Event 2023

  • Anurag Relan, Chief Medical Officer
  • Jeroen Wakkerman, CFO
  • Sijmen de Vries, CEO

Top 10 Holders of Pharming Group NV

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
RTW Investments LP 5.06 33,242,420 0.00 Stakes 5/10/23
Acadian Asset Management LLC 3.07 19,982,959 0.00 Stakes 9/1/22
Victory Capital Management, Inc. (Investment Management) 1.35 8,781,241 0.00 Funds 1/31/23
Healthinvest Partners AB 0.96 6,250,000 0.00 Funds 6/30/22
Norges Bank Investment Management 0.71 4,616,452 0.00 Funds 12/31/22
Bessemer Investment Management LLC 0.52 3,426,413 0.00 Funds 1/31/23
Nordea Investment Management AB 0.49 3,227,847 0.00 Funds 4/28/23
Dimensional Fund Advisors LP 0.42 2,730,579 0.00 Funds 4/28/23
KBC Asset Management NV 0.24 1,583,191 0.00 Funds 12/31/22
Allspring Global Investments LLC 0.23 1,507,437 0.00 Funds 10/31/22

Top 10 Holders of Pharming Group NV ADR RegS

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Cowen Prime Advisors LLC 0.03 22,460 0.27 13F 3/31/23
Morgan Stanley Smith Barney LLC 0.00 2,500 0.03 13F 3/31/23
Geode Capital Management LLC 0.00 2,093 0.03 Funds 4/30/23
UBS Securities LLC 0.00 881 0.01 13F 3/31/23
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.